FEops HEARTguide Simulation Application
Interventional Cardiovascular Implant Simulation Software Device. 510(k) K250635, from Feops NV (Gent, BE). Product code QQI, class 2.
As of Nov 22, 2026, K250635 is an FDA 510(k) held by Feops NV, substantially equivalent on Nov 25, 2025 after 267 days, with no recalls tied to it in FDA's recall database.
- Review time: 267 days
- Recalls: 0
FEops HEARTguideâ„¢ Simulation Application is indicated for patient-specific simulation of transcatheter left atrial appendage occlusion (LAAO) device implantation during procedural planning. The software performs computer simulation to predict implant frame deformation to support the evaluation for LAAO device size and placement.
- FEops HEARTguideK214066 · Feops NV · Feb 25, 2022
- PrecisionTAVI (v1.1)K223809 · Dasi Simulations · May 30, 2023
- FEops HEARTguideK214066 · Feops NV · Feb 25, 2022
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 3, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1405
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files